Salvo E C, Luntz M H, Medow N B
Manhattan Eye, Ear, and Throat Hospital, New York, NY, USA.
Ophthalmic Surg Lasers. 1999 Apr;30(4):271-5.
American Glaucoma Society members were surveyed to determine the pattern of use of viscoelastics for anterior chamber reformation at the slit-lamp in the post-operative clinical management of patients who have undergone trabeculectomy in order to give ophthalmologists an indication of how these materials are being used by their colleagues.
We surveyed 196 members of the American Glaucoma Society regarding the following; (1) whether they inject viscoelastic post-operatively at the slit-lamp as an in-office procedure, (2) the type of viscoelastic used most often, (3) the criteria for injection of viscoelastic, (4) the time to first follow-up, (5) the average number of injections, and (6) the occurrence of post-injection endophthalmitis.
One hundred twenty-five (64%) of the 196 mailed surveys were answered and returned. Ninety-four (75%) of the respondents reported injecting viscoelastics in the postoperative period at the slit-lamp as an in-office procedure. Healon (60%) (Pharmacia & Upjohn Co, Kalamazoo, MI), Viscoat (17%) (Alcon, Ft. Worth, TX), and Healon GV (7%) (Pharmacia & Upjohn Co, Kalamazoo, MI) were the three most often used viscoelastics. Hypotony, iriscornea touch, and lens-cornea touch were given as criteria for injection 19%, 47%, and 88% of the time, respectively. Range of time to first follow-up was 1 hour to 7 days, with a mean time of 1 day. Range of average number of injections was 1 to 3 with a mean of 2 injections for patients requiring injection. Only one respondent reported an incidence of endophthalmitis.
The use of viscoelastic materials in the postoperative trabeculectomy patient in the office at the slit-lamp for anterior chamber reformation is a prevalent practice. Healon is the most commonly used viscoelastic postoperatively and lens-corneal touch is the most common criterion for injection. The average number of injections is 2, with a mean and mode follow-up time of 1 day. Endophthalmitis is a rare complication.
对美国青光眼协会成员进行调查,以确定在小梁切除术后患者的门诊临床管理中,于裂隙灯下进行前房重建时粘弹剂的使用模式,从而为眼科医生提供其同行使用这些材料情况的参考。
我们就以下方面对196名美国青光眼协会成员进行了调查:(1)他们是否在术后于裂隙灯下作为门诊操作注射粘弹剂;(2)最常使用的粘弹剂类型;(3)注射粘弹剂的标准;(4)首次随访时间;(5)平均注射次数;(6)注射后眼内炎的发生率。
196份邮寄调查问卷中有125份(64%)被回复并寄回。94名(75%)受访者报告在术后于裂隙灯下作为门诊操作注射粘弹剂。Healon(60%)(法玛西亚普强公司,密歇根州卡拉马祖)、Viscoat(17%)(爱尔康公司,德克萨斯州沃思堡)和Healon GV(7%)(法玛西亚普强公司,密歇根州卡拉马祖)是三种最常使用的粘弹剂。低眼压、虹膜角膜接触和晶状体角膜接触分别在19%、47%和88%的时间被作为注射标准。首次随访时间范围为1小时至7天,平均时间为1天。需要注射的患者平均注射次数范围为1至3次,平均为2次。只有一名受访者报告了眼内炎的发生率。
在门诊裂隙灯下对小梁切除术后患者使用粘弹剂材料进行前房重建是一种普遍的做法。Healon是术后最常用的粘弹剂,晶状体角膜接触是最常见的注射标准。平均注射次数为2次,平均和众数随访时间为1天。眼内炎是一种罕见的并发症。